Catalyst Wire Dossier Catalyst Wire Dossier

Vemliver

· Daewoong Pharmaceutical Co. LTD
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vemliver, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir [Phase 4]

See pricing